Wall Street Analysts Think Mersana Therapeutics (MRSN) Could Surge 248.83%: Read This Before Placing a Bet

Mersana Therapeutics, Inc. (MRSN) closed the last trading session at $8.11, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $28.29 indicates a 248.8% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $16.09. While the lowest estimate of $8.00 indicates a 1.4% decline from the current price level, the most optimisti ...